Oral Salmon Calcitonin
Multi-site phase IIa study of 277 post-menopausal women administered placebo or one of five oral dosing regimens for 3 months
Long term toxicity studies completed
To assess the efficacy and safety of various doses of the oral tablet formulation of calcitonin
To confirm the activity of calcitonin when given orally, as reflected by changes in markers of bone formation or resorption
Clinical Stage Partnerships